Steward Partners Investment Advisory LLC Grows Stake in Thermo Fisher Scientific Inc. (TMO)

Steward Partners Investment Advisory LLC grew its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 182.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 24,402 shares of the medical research company’s stock after acquiring an additional 15,763 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Thermo Fisher Scientific were worth $4,633,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Bank of Nova Scotia Trust Co. purchased a new stake in shares of Thermo Fisher Scientific during the 3rd quarter valued at approximately $106,000. Ropes Wealth Advisors LLC lifted its stake in shares of Thermo Fisher Scientific by 15.8% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after buying an additional 97 shares in the last quarter. Atlantic Trust LLC purchased a new stake in shares of Thermo Fisher Scientific during the 2nd quarter valued at approximately $138,000. Acrospire Investment Management LLC lifted its stake in shares of Thermo Fisher Scientific by 66.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the medical research company’s stock valued at $174,000 after buying an additional 400 shares in the last quarter. Finally, Glassman Wealth Services lifted its stake in shares of Thermo Fisher Scientific by 23.1% during the 2nd quarter. Glassman Wealth Services now owns 1,039 shares of the medical research company’s stock valued at $181,000 after buying an additional 195 shares in the last quarter. 86.22% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages recently commented on TMO. Jefferies Group restated a “hold” rating and set a $195.00 price target on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Leerink Swann restated an “outperform” rating and set a $200.00 price target (down from $216.00) on shares of Thermo Fisher Scientific in a research note on Monday, December 4th. BTIG Research began coverage on shares of Thermo Fisher Scientific in a research note on Friday, January 5th. They issued a “buy” rating and a $230.00 target price on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a research note on Saturday. Finally, Goldman Sachs Group began coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $212.21.

In other news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the transaction, the chief executive officer now owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.49% of the stock is owned by corporate insiders.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $213.51 on Monday. Thermo Fisher Scientific Inc. has a 52 week low of $140.00 and a 52 week high of $214.57. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market cap of $85,616.52, a P/E ratio of 36.25, a price-to-earnings-growth ratio of 1.74 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the prior year, the company posted $2.03 EPS. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. equities analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, January 15th. Stockholders of record on Friday, December 15th were issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend was Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://sportsperspectives.com/2018/01/22/steward-partners-investment-advisory-llc-grows-stake-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply